Unger P - Search Results

1

Molecular load of pathologically occult metastases in pelvic lymph nodes is an independent prognostic marker of biochemical failure after localized prostate cancer treatment.

Ferrari AC, Stone NN, Kurek R, Mulligan E, McGregor R, Stock R, Unger P, Tunn U, Kaisary A, Droller M, Hall S, Renneberg H, Livak KJ, Gallagher RE, Mandeli J. Ferrari AC, et al. Among authors: unger p. J Clin Oncol. 2006 Jul 1;24(19):3081-8. doi: 10.1200/JCO.2005.03.6020. J Clin Oncol. 2006. PMID: 16809733 Clinical Trial.

2

Prospective analysis of prostate-specific markers in pelvic lymph nodes of patients with high-risk prostate cancer.

Ferrari AC, Stone NN, Eyler JN, Gao M, Mandeli J, Unger P, Gallagher RE, Stock R. Ferrari AC, et al. Among authors: unger p. J Natl Cancer Inst. 1997 Oct 15;89(20):1498-504. doi: 10.1093/jnci/89.20.1498. J Natl Cancer Inst. 1997. PMID: 9337346

3

Histological patterns and associated PSA levels for prostatic adenocarcinoma following brachytherapy.

Xiao GQ, Huan Y, Stone N, Stock R, Unger PD. Xiao GQ, et al. Pathol Res Pract. 2009;205(12):843-6. doi: 10.1016/j.prp.2009.07.009. Epub 2009 Jul 30. Pathol Res Pract. 2009. PMID: 19646822

4

Factors associated with late local failure and its influence on survival in men undergoing prostate brachytherapy.

Stone NN, Unger PD, Sheu R, Rosenstein BS, Stock RG. Stone NN, et al. Brachytherapy. 2022 Jul-Aug;21(4):460-467. doi: 10.1016/j.brachy.2022.01.001. Epub 2022 Feb 3. Brachytherapy. 2022. PMID: 35123886

5

Seminal vesicle biopsy and laparoscopic pelvic lymph node dissection: implications for patient selection in the radiotherapeutic management of prostate cancer.

Stock RG, Stone NN, Ianuzzi C, Unger P. Stock RG, et al. Among authors: unger p. Int J Radiat Oncol Biol Phys. 1995 Nov 1;33(4):815-21. doi: 10.1016/0360-3016(95)02007-4. Int J Radiat Oncol Biol Phys. 1995. PMID: 7591888

6

Indications for seminal vesicle biopsy and laparoscopic pelvic lymph node dissection in men with localized carcinoma of the prostate.

Stone NN, Stock RG, Unger P. Stone NN, et al. Among authors: unger p. J Urol. 1995 Oct;154(4):1392-6. J Urol. 1995. PMID: 7658545 Clinical Trial.

7

Laparoscopic pelvic lymph node dissection for prostate cancer: comparison of the extended and modified techniques.

Stone NN, Stock RG, Unger P. Stone NN, et al. Among authors: unger p. J Urol. 1997 Nov;158(5):1891-4. doi: 10.1016/s0022-5347(01)64161-2. J Urol. 1997. PMID: 9334624 Clinical Trial.

8

Perineural invasion and seminal vesicle involvement predict pelvic lymph node metastasis in men with localized carcinoma of the prostate.

Stone NN, Stock RG, Parikh D, Yeghiayan P, Unger P. Stone NN, et al. Among authors: unger p. J Urol. 1998 Nov;160(5):1722-6. J Urol. 1998. PMID: 9783940

9

Distant and local recurrence in patients with biochemical failure after prostate brachytherapy.

Stock RG, Cesaretti JA, Unger P, Stone NN. Stock RG, et al. Among authors: unger p. Brachytherapy. 2008 Jul-Sep;7(3):217-22. doi: 10.1016/j.brachy.2008.04.002. Brachytherapy. 2008. PMID: 18635024

10

KLF6 loss of function in human prostate cancer progression is implicated in resistance to androgen deprivation.

Liu X, Gomez-Pinillos A, Loder C, Carrillo-de Santa Pau E, Qiao R, Unger PD, Kurek R, Oddoux C, Melamed J, Gallagher RE, Mandeli J, Ferrari AC. Liu X, et al. Am J Pathol. 2012 Sep;181(3):1007-16. doi: 10.1016/j.ajpath.2012.06.008. Epub 2012 Jul 20. Am J Pathol. 2012. PMID: 22819534 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

511 results

Search Page

Filters